当前位置:首页 - 行情中心 - 华海药业(600521) - 财务分析 - 现金流量表

华海药业

(600521)

  

流通市值:288.52亿  总市值:288.52亿
流通股本:14.97亿   总股本:14.97亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金4,433,984,374.732,294,859,508.89,035,678,576.677,196,987,820.31
  收到的税费返还57,310,887.5114,498,857.71240,360,732.18183,390,907.2
  收到其他与经营活动有关的现金106,817,061.3530,640,225.51291,206,417.02225,826,912.79
  经营活动现金流入小计4,598,112,323.592,339,998,592.029,567,245,725.877,606,205,640.3
  购买商品、接受劳务支付的现金1,626,867,295.49770,594,306.262,333,664,987.552,269,316,191.63
  支付给职工以及为职工支付的现金950,118,265.94531,009,002.341,664,807,572.341,257,345,619.29
  支付的各项税费418,875,420242,961,786.49808,671,410.35660,225,730.5
  支付其他与经营活动有关的现金1,232,613,629.63600,325,838.072,587,437,831.821,541,934,311.75
  经营活动现金流出小计4,228,474,611.062,144,890,933.167,394,581,802.065,728,821,853.17
  经营活动产生的现金流量净额369,637,712.53195,107,658.862,172,663,923.811,877,383,787.13
二、投资活动产生的现金流量:
  收回投资收到的现金--6,050,627.356,030,415.64
  取得投资收益收到的现金159,980.7834,013.7462,253.22428,801.16
  处置固定资产、无形资产和其他长期资产收回的现金净额1,194,46033,0005,197,349.522,589,148.23
  收到的其他与投资活动有关的现金75,150,00020,000,00020,000,000-
  投资活动现金流入小计76,504,440.7820,067,013.731,710,230.099,048,365.03
  购建固定资产、无形资产和其他长期资产支付的现金770,274,761.71385,576,040.731,853,335,193.381,134,279,640.18
  投资支付的现金30,000,00021,500,00078,620,923.7460,026,473.74
  支付其他与投资活动有关的现金75,150,00045,150,00020,030,135.1830,135.18
  投资活动现金流出小计875,424,761.71452,226,040.731,951,986,252.31,194,336,249.1
  投资活动产生的现金流量净额-798,920,320.93-432,159,027.03-1,920,276,022.21-1,185,287,884.07
三、筹资活动产生的现金流量:
  吸收投资收到的现金591,515,088.97591,515,088.97--
  取得借款收到的现金1,353,233,056.91945,986,9806,201,877,6104,012,608,010
  收到其他与筹资活动有关的现金200,000,000200,000,000--
  筹资活动现金流入小计2,144,748,145.881,737,502,068.976,201,877,6104,012,608,010
  偿还债务支付的现金1,517,095,000740,040,0005,615,552,349.843,983,809,300
  分配股利、利润或偿付利息支付的现金84,217,751.9335,494,312.1506,835,414.5428,305,808.96
  其中:子公司支付给少数股东的股利、利润11,870,802.5-31,470,802.511,870,802.5
  支付其他与筹资活动有关的现金14,392,338.636,339,157.78212,401,911.93206,704,634.3
  筹资活动现金流出小计1,615,705,090.56781,873,469.886,334,789,676.274,618,819,743.26
  筹资活动产生的现金流量净额529,043,055.32955,628,599.09-132,912,066.27-606,211,733.26
四、汇率变动对现金及现金等价物的影响7,777,954.175,149,356.7451,158,021.95669,731.69
五、现金及现金等价物净增加额107,538,401.09723,726,587.66170,633,857.2886,553,901.49
  加:期初现金及现金等价物余额1,477,600,220.011,477,600,220.011,306,966,362.731,306,966,362.73
  期末现金及现金等价物余额1,585,138,621.12,201,326,807.671,477,600,220.011,393,520,264.22
补充资料:
  净利润405,158,861.54-1,107,463,116.83-
  资产减值准备54,290,859.75-122,874,355.27-
  固定资产和投资性房地产折旧428,986,750.01-803,234,363.56-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧428,986,750.01-803,234,363.56-
  无形资产摊销60,441,819.91-113,539,469.6-
  长期待摊费用摊销6,901,608.96-15,804,713.53-
  处置固定资产、无形资产和其他长期资产的损失14,072.93--2,333,721.93-
  固定资产报废损失2,626,083.63-8,709,957.24-
  公允价值变动损失-32,699,755.78-69,493,156.45-
  财务费用110,204,782.05-139,337,388.45-
  投资损失12,094,720.76-28,227,510.13-
  递延所得税1,917,077.02--17,682,685.13-
  其中:递延所得税资产减少1,917,077.02--17,682,685.13-
  存货的减少-233,596,825.81--78,327,395.16-
  经营性应收项目的减少-135,192,077.57--786,087,193.98-
  经营性应付项目的增加-330,549,917.98-597,684,896.15-
  其他6,457,221.72-14,142,417.74-
  现金的期末余额1,585,138,621.1-1,477,600,220.01-
  减:现金的期初余额1,477,600,220.01-1,306,966,362.73-
  现金及现金等价物的净增加额107,538,401.09-170,633,857.28-
公告日期2025-08-262025-04-302025-04-302024-10-31
审计意见(境内)标准无保留意见
TOP↑